We assign a fundamental rating of 7 out of 10 to INMD. INMD was compared to 186 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making INMD a very profitable company, without any liquidiy or solvency issues. A decent growth rate in combination with a cheap valuation! Better keep an eye on INMD. This makes INMD very considerable for value investing!

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

INMD had positive earnings in the past year.
INMD had a positive operating cash flow in the past year.
INMD had positive earnings in each of the past 5 years.
In the past 5 years INMD always reported a positive cash flow from operatings.

1.2 Ratios

With an excellent Return On Assets value of 20.39%, INMD belongs to the best of the industry, outperforming 99.46% of the companies in the same industry.
INMD has a better Return On Equity (22.93%) than 95.68% of its industry peers.
Looking at the Return On Invested Capital, with a value of 11.95%, INMD belongs to the top of the industry, outperforming 92.43% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for INMD is significantly above the industry average of 8.81%.
The last Return On Invested Capital (11.95%) for INMD is well below the 3 year average (22.89%), which needs to be investigated, but indicates that INMD had better years and this may not be a problem.

		Industry Rank	Sector Rank
ROA	20.39%
ROE	22.93%
ROIC	11.95%

ROA(3y)23.69%

ROA(5y)26.18%

ROE(3y)26.67%

ROE(5y)29.84%

ROIC(3y)22.89%

ROIC(5y)25.97%

1.3 Margins

INMD has a Profit Margin of 41.10%. This is amongst the best in the industry. INMD outperforms 99.46% of its industry peers.
INMD's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 23.98%, INMD belongs to the best of the industry, outperforming 94.59% of the companies in the same industry.
In the last couple of years the Operating Margin of INMD has declined.
INMD's Gross Margin of 78.82% is amongst the best of the industry. INMD outperforms 91.89% of its industry peers.
In the last couple of years the Gross Margin of INMD has declined.

		Industry Rank	Sector Rank
OM	23.98%
PM (TTM)	41.1%
GM	78.82%

OM growth 3Y-15.26%

OM growth 5Y-5.64%

PM growth 3Y-0.16%

PM growth 5Y3.28%

GM growth 3Y-1.88%

GM growth 5Y-1.59%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

INMD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, INMD has less shares outstanding
Compared to 5 years ago, INMD has more shares outstanding
There is no outstanding debt for INMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

INMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	N/A

ROIC/WACC1.37

WACC8.73%

2.3 Liquidity

INMD has a Current Ratio of 9.75. This indicates that INMD is financially healthy and has no problem in meeting its short term obligations.
INMD's Current ratio of 9.75 is amongst the best of the industry. INMD outperforms 91.89% of its industry peers.
A Quick Ratio of 8.71 indicates that INMD has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 8.71, INMD belongs to the best of the industry, outperforming 91.35% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	9.75
Quick Ratio	8.71

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for INMD have decreased strongly by -23.67% in the last year.
INMD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.97% yearly.
The Revenue for INMD has decreased by -13.98% in the past year. This is quite bad
Measured over the past years, INMD shows a very strong growth in Revenue. The Revenue has been growing by 20.35% on average per year.

EPS 1Y (TTM)-23.67%

EPS 3Y-4.52%

EPS 5Y22.97%

EPS Q2Q%-45.71%

Revenue 1Y (TTM)-13.98%

Revenue growth 3Y3.36%

Revenue growth 5Y20.35%

Sales Q2Q%-28.46%

3.2 Future

The Earnings Per Share is expected to grow by 0.50% on average over the next years.
The Revenue is expected to decrease by -0.25% on average over the next years.

EPS Next Y-9.69%

EPS Next 2Y-2.84%

EPS Next 3Y0.5%

EPS Next 5YN/A

Revenue Next Year-8.36%

Revenue Next 2Y-2.69%

Revenue Next 3Y-0.25%

Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.94 indicates a reasonable valuation of INMD.
95.14% of the companies in the same industry are more expensive than INMD, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of INMD to the average of the S&P500 Index (28.32), we can say INMD is valued rather cheaply.
INMD is valuated reasonably with a Price/Forward Earnings ratio of 9.35.
INMD's Price/Forward Earnings ratio is rather cheap when compared to the industry. INMD is cheaper than 95.68% of the companies in the same industry.
INMD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.57.

		Industry Rank	Sector Rank
PE	9.94
Fwd PE	9.35

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INMD indicates a rather cheap valuation: INMD is cheaper than 98.92% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of INMD indicates a rather cheap valuation: INMD is cheaper than 97.84% of the companies listed in the same industry.